Global Companion Diagnostic Market Size, Status and Forecast 2024-2031

Report ID: 954703 | Published Date: Jan 2026 | No. of Page: 108 | Base Year: 2025 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Companion Diagnostic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Immunohistochemistry
        1.2.3 Molecular Diagnosis
    1.3 Market by Application
        1.3.1 Global Companion Diagnostic Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Oncology
        1.3.3 Cardiovascular
        1.3.4 Central Nervous System
        1.3.5 Virology
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Companion Diagnostic Market Perspective (2016-2027)
    2.2 Companion Diagnostic Growth Trends by Regions
        2.2.1 Companion Diagnostic Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Companion Diagnostic Historic Market Share by Regions (2016-2021)
        2.2.3 Companion Diagnostic Forecasted Market Size by Regions (2022-2027)
    2.3 Companion Diagnostic Industry Dynamic
        2.3.1 Companion Diagnostic Market Trends
        2.3.2 Companion Diagnostic Market Drivers
        2.3.3 Companion Diagnostic Market Challenges
        2.3.4 Companion Diagnostic Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Companion Diagnostic Players by Revenue
        3.1.1 Global Top Companion Diagnostic Players by Revenue (2016-2021)
        3.1.2 Global Companion Diagnostic Revenue Market Share by Players (2016-2021)
    3.2 Global Companion Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Companion Diagnostic Revenue
    3.4 Global Companion Diagnostic Market Concentration Ratio
        3.4.1 Global Companion Diagnostic Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostic Revenue in 2020
    3.5 Companion Diagnostic Key Players Head office and Area Served
    3.6 Key Players Companion Diagnostic Product Solution and Service
    3.7 Date of Enter into Companion Diagnostic Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostic Breakdown Data by Type
    4.1 Global Companion Diagnostic Historic Market Size by Type (2016-2021)
    4.2 Global Companion Diagnostic Forecasted Market Size by Type (2022-2027)

5 Companion Diagnostic Breakdown Data by Application
    5.1 Global Companion Diagnostic Historic Market Size by Application (2016-2021)
    5.2 Global Companion Diagnostic Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Companion Diagnostic Market Size (2016-2027)
    6.2 North America Companion Diagnostic Market Size by Type
        6.2.1 North America Companion Diagnostic Market Size by Type (2016-2021)
        6.2.2 North America Companion Diagnostic Market Size by Type (2022-2027)
        6.2.3 North America Companion Diagnostic Market Size by Type (2016-2027)
    6.3 North America Companion Diagnostic Market Size by Application
        6.3.1 North America Companion Diagnostic Market Size by Application (2016-2021)
        6.3.2 North America Companion Diagnostic Market Size by Application (2022-2027)
        6.3.3 North America Companion Diagnostic Market Size by Application (2016-2027)
    6.4 North America Companion Diagnostic Market Size by Country
        6.4.1 North America Companion Diagnostic Market Size by Country (2016-2021)
        6.4.2 North America Companion Diagnostic Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Companion Diagnostic Market Size (2016-2027)
    7.2 Europe Companion Diagnostic Market Size by Type
        7.2.1 Europe Companion Diagnostic Market Size by Type (2016-2021)
        7.2.2 Europe Companion Diagnostic Market Size by Type (2022-2027)
        7.2.3 Europe Companion Diagnostic Market Size by Type (2016-2027)
    7.3 Europe Companion Diagnostic Market Size by Application
        7.3.1 Europe Companion Diagnostic Market Size by Application (2016-2021)
        7.3.2 Europe Companion Diagnostic Market Size by Application (2022-2027)
        7.3.3 Europe Companion Diagnostic Market Size by Application (2016-2027)
    7.4 Europe Companion Diagnostic Market Size by Country
        7.4.1 Europe Companion Diagnostic Market Size by Country (2016-2021)
        7.4.2 Europe Companion Diagnostic Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Companion Diagnostic Market Size (2016-2027)
    8.2 Asia-Pacific Companion Diagnostic Market Size by Type
        8.2.1 Asia-Pacific Companion Diagnostic Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Companion Diagnostic Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Companion Diagnostic Market Size by Type (2016-2027)
    8.3 Asia-Pacific Companion Diagnostic Market Size by Application
        8.3.1 Asia-Pacific Companion Diagnostic Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Companion Diagnostic Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Companion Diagnostic Market Size by Application (2016-2027)
    8.4 Asia-Pacific Companion Diagnostic Market Size by Region
        8.4.1 Asia-Pacific Companion Diagnostic Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Companion Diagnostic Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Companion Diagnostic Market Size (2016-2027)
    9.2 Latin America Companion Diagnostic Market Size by Type
        9.2.1 Latin America Companion Diagnostic Market Size by Type (2016-2021)
        9.2.2 Latin America Companion Diagnostic Market Size by Type (2022-2027)
        9.2.3 Latin America Companion Diagnostic Market Size by Type (2016-2027)
    9.3 Latin America Companion Diagnostic Market Size by Application
        9.3.1 Latin America Companion Diagnostic Market Size by Application (2016-2021)
        9.3.2 Latin America Companion Diagnostic Market Size by Application (2022-2027)
        9.3.3 Latin America Companion Diagnostic Market Size by Application (2016-2027)
    9.4 Latin America Companion Diagnostic Market Size by Country
        9.4.1 Latin America Companion Diagnostic Market Size by Country (2016-2021)
        9.4.2 Latin America Companion Diagnostic Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Companion Diagnostic Market Size (2016-2027)
    10.2 Middle East & Africa Companion Diagnostic Market Size by Type
        10.2.1 Middle East & Africa Companion Diagnostic Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Companion Diagnostic Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Companion Diagnostic Market Size by Type (2016-2027)
    10.3 Middle East & Africa Companion Diagnostic Market Size by Application
        10.3.1 Middle East & Africa Companion Diagnostic Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Companion Diagnostic Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Companion Diagnostic Market Size by Application (2016-2027)
    10.4 Middle East & Africa Companion Diagnostic Market Size by Country
        10.4.1 Middle East & Africa Companion Diagnostic Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Companion Diagnostic Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Roche Holdings
        11.1.1 Roche Holdings Company Details
        11.1.2 Roche Holdings Business Overview
        11.1.3 Roche Holdings Companion Diagnostic Introduction
        11.1.4 Roche Holdings Revenue in Companion Diagnostic Business (2016-2021)
        11.1.5 Roche Holdings Recent Development
    11.2 Abbott Laboratories
        11.2.1 Abbott Laboratories Company Details
        11.2.2 Abbott Laboratories Business Overview
        11.2.3 Abbott Laboratories Companion Diagnostic Introduction
        11.2.4 Abbott Laboratories Revenue in Companion Diagnostic Business (2016-2021)
        11.2.5 Abbott Laboratories Recent Development
    11.3 Thermo Fisher Scientific
        11.3.1 Thermo Fisher Scientific Company Details
        11.3.2 Thermo Fisher Scientific Business Overview
        11.3.3 Thermo Fisher Scientific Companion Diagnostic Introduction
        11.3.4 Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2016-2021)
        11.3.5 Thermo Fisher Scientific Recent Development
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Details
        11.4.2 Agilent Technologies Business Overview
        11.4.3 Agilent Technologies Companion Diagnostic Introduction
        11.4.4 Agilent Technologies Revenue in Companion Diagnostic Business (2016-2021)
        11.4.5 Agilent Technologies Recent Development
    11.5 Merck
        11.5.1 Merck Company Details
        11.5.2 Merck Business Overview
        11.5.3 Merck Companion Diagnostic Introduction
        11.5.4 Merck Revenue in Companion Diagnostic Business (2016-2021)
        11.5.5 Merck Recent Development
    11.6 Agendia
        11.6.1 Agendia Company Details
        11.6.2 Agendia Business Overview
        11.6.3 Agendia Companion Diagnostic Introduction
        11.6.4 Agendia Revenue in Companion Diagnostic Business (2016-2021)
        11.6.5 Agendia Recent Development
    11.7 Qiagen
        11.7.1 Qiagen Company Details
        11.7.2 Qiagen Business Overview
        11.7.3 Qiagen Companion Diagnostic Introduction
        11.7.4 Qiagen Revenue in Companion Diagnostic Business (2016-2021)
        11.7.5 Qiagen Recent Development
    11.8 Myriad Genetics
        11.8.1 Myriad Genetics Company Details
        11.8.2 Myriad Genetics Business Overview
        11.8.3 Myriad Genetics Companion Diagnostic Introduction
        11.8.4 Myriad Genetics Revenue in Companion Diagnostic Business (2016-2021)
        11.8.5 Myriad Genetics Recent Development
    11.9 Advanced Cell Diagnostics
        11.9.1 Advanced Cell Diagnostics Company Details
        11.9.2 Advanced Cell Diagnostics Business Overview
        11.9.3 Advanced Cell Diagnostics Companion Diagnostic Introduction
        11.9.4 Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2016-2021)
        11.9.5 Advanced Cell Diagnostics Recent Development
    11.10 Danaher
        11.10.1 Danaher Company Details
        11.10.2 Danaher Business Overview
        11.10.3 Danaher Companion Diagnostic Introduction
        11.10.4 Danaher Revenue in Companion Diagnostic Business (2016-2021)
        11.10.5 Danaher Recent Development
    11.11 Illumina, Inc
        11.11.1 Illumina, Inc Company Details
        11.11.2 Illumina, Inc Business Overview
        11.11.3 Illumina, Inc Companion Diagnostic Introduction
        11.11.4 Illumina, Inc Revenue in Companion Diagnostic Business (2016-2021)
        11.11.5 Illumina, Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Companion Diagnostic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Immunohistochemistry
    Table 3. Key Players of Molecular Diagnosis
    Table 4. Global Companion Diagnostic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Companion Diagnostic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Companion Diagnostic Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Companion Diagnostic Market Share by Regions (2016-2021)
    Table 8. Global Companion Diagnostic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Companion Diagnostic Market Share by Regions (2022-2027)
    Table 10. Companion Diagnostic Market Trends
    Table 11. Companion Diagnostic Market Drivers
    Table 12. Companion Diagnostic Market Challenges
    Table 13. Companion Diagnostic Market Restraints
    Table 14. Global Companion Diagnostic Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Companion Diagnostic Market Share by Players (2016-2021)
    Table 16. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic as of 2020)
    Table 17. Ranking of Global Top Companion Diagnostic Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Companion Diagnostic Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Companion Diagnostic Product Solution and Service
    Table 21. Date of Enter into Companion Diagnostic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Companion Diagnostic Revenue Market Share by Type (2016-2021)
    Table 25. Global Companion Diagnostic Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Companion Diagnostic Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Companion Diagnostic Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Companion Diagnostic Revenue Market Share by Application (2016-2021)
    Table 29. Global Companion Diagnostic Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Companion Diagnostic Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Companion Diagnostic Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Companion Diagnostic Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Companion Diagnostic Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Companion Diagnostic Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Companion Diagnostic Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Companion Diagnostic Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Companion Diagnostic Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Companion Diagnostic Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Roche Holdings Company Details
    Table 62. Roche Holdings Business Overview
    Table 63. Roche Holdings Companion Diagnostic Product
    Table 64. Roche Holdings Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 65. Roche Holdings Recent Development
    Table 66. Abbott Laboratories Company Details
    Table 67. Abbott Laboratories Business Overview
    Table 68. Abbott Laboratories Companion Diagnostic Product
    Table 69. Abbott Laboratories Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 70. Abbott Laboratories Recent Development
    Table 71. Thermo Fisher Scientific Company Details
    Table 72. Thermo Fisher Scientific Business Overview
    Table 73. Thermo Fisher Scientific Companion Diagnostic Product
    Table 74. Thermo Fisher Scientific Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 75. Thermo Fisher Scientific Recent Development
    Table 76. Agilent Technologies Company Details
    Table 77. Agilent Technologies Business Overview
    Table 78. Agilent Technologies Companion Diagnostic Product
    Table 79. Agilent Technologies Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 80. Agilent Technologies Recent Development
    Table 81. Merck Company Details
    Table 82. Merck Business Overview
    Table 83. Merck Companion Diagnostic Product
    Table 84. Merck Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 85. Merck Recent Development
    Table 86. Agendia Company Details
    Table 87. Agendia Business Overview
    Table 88. Agendia Companion Diagnostic Product
    Table 89. Agendia Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 90. Agendia Recent Development
    Table 91. Qiagen Company Details
    Table 92. Qiagen Business Overview
    Table 93. Qiagen Companion Diagnostic Product
    Table 94. Qiagen Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 95. Qiagen Recent Development
    Table 96. Myriad Genetics Company Details
    Table 97. Myriad Genetics Business Overview
    Table 98. Myriad Genetics Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 99. Myriad Genetics Recent Development
    Table 100. Advanced Cell Diagnostics Company Details
    Table 101. Advanced Cell Diagnostics Business Overview
    Table 102. Advanced Cell Diagnostics Companion Diagnostic Product
    Table 103. Advanced Cell Diagnostics Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 104. Advanced Cell Diagnostics Recent Development
    Table 105. Danaher Company Details
    Table 106. Danaher Business Overview
    Table 107. Danaher Companion Diagnostic Product
    Table 108. Danaher Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 109. Danaher Recent Development
    Table 110. Illumina, Inc Company Details
    Table 111. Illumina, Inc Business Overview
    Table 112. Illumina, Inc Companion Diagnostic Product
    Table 113. Illumina, Inc Revenue in Companion Diagnostic Business (2016-2021) & (US$ Million)
    Table 114. Illumina, Inc Recent Development
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Companion Diagnostic Market Share by Type: 2020 VS 2027
    Figure 2. Immunohistochemistry Features
    Figure 3. Molecular Diagnosis Features
    Figure 4. Global Companion Diagnostic Market Share by Application: 2020 VS 2027
    Figure 5. Oncology Case Studies
    Figure 6. Cardiovascular Case Studies
    Figure 7. Central Nervous System Case Studies
    Figure 8. Virology Case Studies
    Figure 9. Others Case Studies
    Figure 10. Companion Diagnostic Report Years Considered
    Figure 11. Global Companion Diagnostic Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Companion Diagnostic Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Companion Diagnostic Market Share by Regions: 2020 VS 2027
    Figure 14. Global Companion Diagnostic Market Share by Regions (2022-2027)
    Figure 15. Global Companion Diagnostic Market Share by Players in 2020
    Figure 16. Global Top Companion Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Companion Diagnostic as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Companion Diagnostic Revenue in 2020
    Figure 18. Global Companion Diagnostic Revenue Market Share by Type (2016-2021)
    Figure 19. Global Companion Diagnostic Revenue Market Share by Type (2022-2027)
    Figure 20. North America Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Companion Diagnostic Market Share by Type (2016-2027)
    Figure 22. North America Companion Diagnostic Market Share by Application (2016-2027)
    Figure 23. North America Companion Diagnostic Market Share by Country (2016-2027)
    Figure 24. United States Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Companion Diagnostic Market Share by Type (2016-2027)
    Figure 28. Europe Companion Diagnostic Market Share by Application (2016-2027)
    Figure 29. Europe Companion Diagnostic Market Share by Country (2016-2027)
    Figure 30. Germany Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Companion Diagnostic Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Companion Diagnostic Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Companion Diagnostic Market Share by Region (2016-2027)
    Figure 40. China Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Companion Diagnostic Market Share by Type (2016-2027)
    Figure 48. Latin America Companion Diagnostic Market Share by Application (2016-2027)
    Figure 49. Latin America Companion Diagnostic Market Share by Country (2016-2027)
    Figure 50. Mexico Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Companion Diagnostic Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Companion Diagnostic Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Companion Diagnostic Market Share by Country (2016-2027)
    Figure 56. Turkey Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Companion Diagnostic Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Roche Holdings Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 62. Agilent Technologies Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 63. Merck Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 64. Agendia Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 65. Qiagen Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 66. Myriad Genetics Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 67. Advanced Cell Diagnostics Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 68. Danaher Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 69. Illumina, Inc Revenue Growth Rate in Companion Diagnostic Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Holdings
Abbott Laboratories
Thermo Fisher Scientific
Agilent Technologies
Merck
Agendia
Qiagen
Myriad Genetics
Advanced Cell Diagnostics
Danaher
Illumina, Inc
Frequently Asked Questions
Companion Diagnostic report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Companion Diagnostic report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Companion Diagnostic report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports